2cm 以上的 C-TI-RADS3类甲状腺结节的临床特点分析.

Objective To analyze the clinical characteristics of C-TI-RADS 3 thyroid nodules with a diameter greater than 2 cm and explore their correlation with gender, nodule ingredient, contralateral cancer presence, diffuse echo changes, TPOAB and TGAB. Methods A retrospective analysis was made on the clinical and pathological information of 94 patients with thyroid nodules who were admitted to our department from September 2022 to March 2023. All the patients underwent cytological and/or histopathological examinations. The proportions of TBS I category, benign tumors, low-risk tumors, and malignant tumors were calculated. The proportion of TBS type I, benign tumors, low-risk tumors, and malignant tumors was quantified. Subsequently, a comparative analysis was conducted among the benign, low-risk, and malignant groups in terms of clinical characteristics including gender distribution, nodule composition, contralateral cancer occurrence, diffuse echo changes presence, as well as TPOAB and TGAB levels.Results Seven cases in TBS I category were excluded. Among the remaining 87 cases with confirmed pathology results for nodules, there were 72 benign cases(38 cytology cases and 34 histology cases), 5 low-risk thyroid tumors(2 cytology cases and 3 histology cases), 10 malignant cases(8 PTC cases, 1 FTC case, and 1 MTC case). There was a significant difference in nodule ingredient(cystic/solid)between different pathological types(X²=10.369, P=0.006). However, no statistical significance was found in terms of gender, diffuse echo changes, contralateral cancer presence, TPOAB or TGAB(P>0.05). Further analysis showed that the proportion of solid component was higher in low-risk tumors than in benign nodules(X²=9.571, P=0.002). No statistical significance was found between malignant nodules and low-risk nodules(X²=2.143, P=0.143), or between malignant nodules and benign nodules(X²=2.165, P=0.141). Conclusion Although TI-RADS 3 nodules are generally considered as potentially benign according to various versions of thyroid imaging reporting and data system, malignant nodules still account for a certain proportion. Attention should be paid to thyroid nodules with a typical ultrasonic signs, such as cystic nodules, thyroid follicular tumors and medullary thyroid carcinoma. Ultrasound guided fine needle aspiration cytopathology is necessary for evaluating benign and malignant nodules. It is necessary to pay attention to unsatisfactory or undiagnosable specimens to improve the accuracy of diagnosis. [ABSTRACT FROM AUTHOR]